Can changes in troponin results be useful in diagnosing myocardial infarction?

Clinical Chemistry

Volumn 56, Issue 7, 2010, Pages 1047-1049

  Aakre, Kristin M ^a   Sandberg, Sverre ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I; TROPONIN T;

CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; EDITORIAL; ELECTROCARDIOGRAPHY; HEART INFARCTION; HUMAN; SENSITIVITY AND SPECIFICITY;

BAYES THEOREM; HUMANS; MODELS, BIOLOGICAL; MYOCARDIAL INFARCTION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TROPONIN I; TROPONIN T;

EID: 77954373519     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.146639     Document Type: Editorial

References (15)

1. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 1979;59:607-9.
2. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol 2007;50:2173-95.
3. Jaffe AS, Ravkilde J, Roberts R, Naslund U, Apple FS, Galvani M, Katus H. It's time for a change to a troponin standard. Circulation 2000;102:1216-20.
4. Wu AH, Jaffe AS, Apple FS, Jesse RL, Francis GL, Morrow DA, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem 2007;53:2086-96.
5. Mingels A, Jacobs L, Michielsen E, Swaanenburg J, Wodzig W, van Dieijen- Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009;55:101-8.
6. Wu AH, Fukushima N, Puskas R, Todd J, Goix P. Development and preliminary clinical validation of a high sensitivity assay for cardiac troponin using a capillary flow (single molecule) fluorescence detector. Clin Chem 2006;52:2157-9.
7. Vasile VC, Saenger AK, Kroning JM, Jaffe AS. Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:1086-90.
8. Wu AH, Lu QA, Todd J, Moecks J, Wians F. Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem 2009;55:52-8.
9. Jacobs LH, van de Kerkhof J, Mingels AM, Kleijnen VW, van der Sande FM, Wodzig WK, et al. Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays. Ann Clin Biochem 2009;46:283-90.
10. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361:858-67.
11. Miller WG, Bruns DE, Hortin GL, Sandberg S, Aakre KM, McQueen MJ, et al. Current issues in measurement and reporting of urinary albumin excretion. Clin Chem 2009;55:24-38.
12. Critical Appraisal Skills Programme (CASP). http://www.phru.nhs.uk/Doc- Links/Diagnostic%20Tests%2012%20Questions.pdf (Accessed April 2010).
13. European Federation of Clinical Chemistry and Laboratory Medicine. http://www.efcclm.org/ (Accessed April 2010).
14. Petersen PH, Sandberg S, Iglesias N, Sölétormos G, Aarsand AK, Brandslund I, Jørgensen LG. 'Likelihood-ratio' and 'odds' applied to monitoring of patients as a supplement to 'reference change value' (RCV). Clin Chem Lab Med 2008;46:157-64.
15. Jaffe AS, Apple FS, Morrow DA, Lindahl B, Katus HA. Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the Definition of Myocardial Infarction. Clin Chem 2010;56:941-3.